Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We utilise our cutting-edge, exclusive workflow to develop focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Utilising molecular simulations, our approach thoroughly examines a wide array of proteins, tracking their conformational changes individually and within complexes. Ensemble virtual screening enables us to address conformational flexibility, revealing essential binding sites at functional regions and allosteric locations. Our rigorous analysis guarantees that no potential mechanism of action is overlooked, aiming to uncover new therapeutic targets and lead compounds across diverse biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
P54368
UPID:
OAZ1_HUMAN
Alternative names:
-
Alternative UPACC:
P54368; O43382; Q14989; Q92595; Q9UPL9
Background:
Ornithine decarboxylase antizyme 1 plays a pivotal role in regulating polyamine biosynthesis and uptake, crucial for cellular growth and differentiation. It inhibits ornithine decarboxylase (ODC) activity, preventing the assembly of functional ODC homodimers, and facilitates their degradation. This protein also modulates the stability of AZIN2 and the cellular uptake of polyamines, showcasing its multifaceted regulatory functions in intracellular polyamine levels.
Therapeutic significance:
Understanding the role of Ornithine decarboxylase antizyme 1 could open doors to potential therapeutic strategies. Its regulatory function in polyamine biosynthesis and cellular uptake positions it as a key target for modulating cellular growth and differentiation, offering avenues for the development of novel treatments.